Trial Details

COMPLETED
Basic Information
Clinical ID c158
Identifier NCT02624037
Trial Title Precision IFX: Using a Dashboard to Individualize Infliximab Dosage
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions OTHER: Individualized Dosage Precision IFX Dashboard
Participant Information
Sponsor Icahn School of Medicine at Mount Sinai
City New York
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2025-01-15
Primary Completion Date 2020-10-21
Completion Date 2020-10-21